M. González-Valentin

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

M. Tormo, J. Hernández-Rivas, A. Oriol, 2002, Haematologica.

Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.

A. Oriol, J. Ribera, J. Ortega, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of High-Risk Acute Lymphoblastic Leukemia. Preliminary Results of the Protocol PETHEMA ALL-93

M. Terol, J. Garcia-conde, J. Miguel, 1998 .

ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN SECOND COMPLETE REMISSION—Similar Outcomes After Matched Related and Unrelated Donor Transplant: A Study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon)

A. Verdeguer, M. Díaz, I. Badell, 2008, Pediatric hematology and oncology.